TY  - JOUR
AU  - González-Juanatey, J R
AU  - Anguita-Sánchez, M
AU  - Bayes-Genís, A
AU  - Comín-Colet, J
AU  - García-Quintana, A
AU  - Recio-Mayoral, A
AU  - Zamorano-Gómez, J L
AU  - Cepeda-Rodrigo, J M
AU  - Manzano, L
PY  - 2022
DO  - 10.1016/j.rceng.2021.12.006
UR  - http://hdl.handle.net/10668/22488
T2  - Revista clinica espanola
AB  - Despite currently available treatments, risk of death and hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF) remains high. The pathophysiology of HFrEF includes neurohormonal activation characterized by stimulation...
LA  - en
KW  - GMPc
KW  - Heart failure
KW  - Insuficiencia cardíaca
KW  - Nitric oxide
KW  - Vericiguat
KW  - cGMP
KW  - Óxido nítrico
KW  - Heart Failure
KW  - Heterocyclic Compounds, 2-Ring
KW  - Humans
KW  - Nitric Oxide
KW  - Pyrimidines
KW  - Stroke Volume
KW  - Ventricular Dysfunction, Left
TI  - Vericiguat in heart failure: From scientific evidence to clinical practice.
TY  - research article
VL  - 222
ER  -